---
title: Changes in cardiac and vascular haemodynamics as potential mediators of improvements
  in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetes
date: '2023-08-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37633072/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230827181309&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Improvements in haemodynamic parameters did not substantially
  mediate empagliflozin benefits on CV and kidney outcomes in patients with T2DM and
  established CV ...'
disable_comments: true
---
CONCLUSIONS: Improvements in haemodynamic parameters did not substantially mediate empagliflozin benefits on CV and kidney outcomes in patients with T2DM and established CV ...